CCND1 and cancer: Finally, CCND1 appears to be an outstanding candidate therapeutic target, and several studies have shown that antisense to CCND1 inhibits the growth and reverses the transformed phenotype of human cancer cells (Zhou et al, 1995; Arber et al, 1997).